Joshua Brody, MD, PhD of Mount Sinai Hospital, discusses how to rationally combine immunotherapies for patients with lymphoma by increasing the specificity of the anti-tumor immune response at the 58th ASH Annual Meeting in San Diego, CA.
Increasing the Specificity of the Anti-Tumor Immune Response in Lymphoma
